Novalyst and AliX agree to merge

Following long-standing cooperation, French companies Novalyst Discovery, a chemistry services group, and AliX, a structural biology firm, have agreed to merge to create a leading contract research organization. Together they have launched NovAliX, a multidisciplinary company providing flexible outsourcing solutions for drug discovery and development.

The combined company will represent a major provider able to deliver comprehensive services from gene to preclinical drug candidates and especially offering alternative fragment-based drug discovery approaches, the firms claim.